the aid library

LIST OPTIONS

Filter

641

Assessment tool for laboratories implementing SARS-CoV-2 testing: Interim Guidance

World Health Organization WHO (2020) C_WHO

User Guide. This Laboratory Assessment Tool (LAT) is specifically designed to assess capacities of existing laboratories which have implemented or aim to implement SARS-CoV-2 testing. It addresses both core capacities of a laboratory and specificities related to SARS-CoV-2 testing. It is a focused... more

Download (236)

View PDF (181)

Testes de diagnóstico para SARS-CoV-2. Guia provisória.11 setembro 2020

Pan American Health Organisation PAHO (2020) C_WHO

Download (483)

View PDF (531)

National Guidelines for Antiretroviral Therapy, 5th ed.

Ministry of Health and Social Services (MOHSS) (2016) C1

Download (194)

View PDF (178)

Tests diagnostiques pour le dépistage du SARS-CoV-2 : orientations provisoires, 11 septembre 2020

World Health Organization WHO (2020) C_WHO

Available in Arabic, Chinese, English, French, Portuguese, Russian and Spanish https://apps.who.int/iris/handle/10665/334254

Download (90)

View PDF (86)

Mpox Testing Strategy - November 2024

Africa Center for Disease Control and Prevention (2024) CC

Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like disease occurred in monkeys kept for research. The first human case was recorde...d in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries. In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response. As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa. more

Download (155)

View PDF (223)

Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities
recommended

World Health Organization WHO (2021) C_WHO

Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national testing strategies and the use of PCR and rapid antigen tests in different transmission scenarios of t... more

Download (129)

View PDF (151)

Especificacoes technicas para selecao de testes diagnosticos in vitro essenciais para SARS-COV-2

Organización Mundial de la Salud OMS OPAS (2021) C_WHO

TECHNICAL SPECIFICATIONS FOR TEST SELECTION ESSENTIAL IN VITRO DIAGNOSTIC TESTS FOR SARS-COV-2

Download (158)

View PDF (163)

Especificacoes tecnicas para selecao de testes diagnosticos in vitro essenciais para SARS-COV-2, 14 de junho de 2021

Organização Mundial da Saúde (OMS) OPAS (2021) C_WHO

Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021

Download (498)

View PDF (779)

Guide to G6PD deficiency rapid diagnostic testing to support P. vivax radical cure

World Health Organization WHO (2018) C_WHO

This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from... more

Download (465)

View PDF (734)

Current Zika Product Pipeline

World Health Organization (2016) C_WHO

3 March 2016

Download (671)

View PDF (841)

Consolidated guidelines on HIV testing services

World Health Organization WHO (2020) C_WHO

These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations. The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr... more

Download (451)

View PDF (823)

Introduction to Ebola disease: Managing infectious hazards
recommended

Formenty, Pierre World Health Organization (WHO) (2018) C_WHO

Download (175)

View PDF (190)

Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended

African Union; Africa CDC Centres for Disease Control and Prevention; AMREF; ASLM; et al. (2021) CC

ASLM in collaboration with the Africa Centres for Disease Control and Prevention, and in partnership with the Clinton Health Access Initiative, Amref and Last Mile Health present the Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19. This framework aims to pr... more

Download (168)

View PDF (209)

Prevention and Treatment of HIV ands other sexually transmitted infections among men who have sex with men and transgender people

World Health Organization; UNAIDS; UNDP; et al. (2011) C_WHO

Recommendations for a public health approach HIV/AIDS Programme

Download (820)

View PDF (2196)

Childhood TB - Training Toolkit

International Union Against Tuberculosis and Lung Disease (2014) CC

The training focuses on building the capacity of health care workers at the primary and secondary level to address and manage TB in children.

Download (306)

View PDF (348)

Guidelines For Safety Assessment of Foods Derived From Genetically Engineered Plants

Indian Council of Medical Research (ICMR) (2012) C1

Original text from 2008, updated in 2012. This document marks the beginning of a structured approach to safety assessment of GE foods, which are yet to be approved in our country. It is understood that many changes will become necessary and will be incorporated as we progress. This document will ho... more

Download (210)

View PDF (247)

Integrating collaborative TB and HIV services within a comprehensive package of care for people who inject drugs

A. Baddeley; H. Getahun; et al. World Health Organization (WHO) (2016) C_WHO

Consolidated Guidelines Geneva, 2016 The End TB Strategy

Download (1623)

View PDF (3305)

Guidelines on Programmatic Management of Drug Resistant TB (PMDT) in India

Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan (2012) CC

Revised National Tuberculosis Control Programme

Download (775)

View PDF (1555)

Guidelines on hepatitis B and C testing
recommended

World Health Organization (WHO) (2017) C_WHO

Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei... more

Download (640)

View PDF (716)

India: National Guidelines for HIV Testing

National AIDS Control Organisation (NACO), Ministry of Health & Family Welfare, Government of India (2015) C1

Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities recommended

Introduction to Ebola disease: Managing infectious hazards recommended

Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19 recommended

Guidelines on hepatitis B and C testing recommended

Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities
recommended

Introduction to Ebola disease: Managing infectious hazards
recommended

Quality Assurance Framework for SARS-CoV-2 Antigen Rapid Testing for Diagnosis of COVID-19
recommended

Guidelines on hepatitis B and C testing
recommended